AFP and hepatocellular carcinoma: In the first study, glypican-3 performed similar to AFP (AUROCs of 0.78 and 0.79, respectively), while their combination had good accuracy (AUROC = 0.94) [28] in discriminating HCC from liver cirrhosis.